Home
/
Petros Pharmaceuticals, Inc.
/
Financials
/
Quarterly
Petros Pharmaceuticals, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Petros Pharmaceuticals, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$1.58M
Nov 13, 2024
Q2
2024
Jun 30, 2024
$1.42M
Aug 14, 2024
Q1
2024
Mar 31, 2024
$1.39M
May 15, 2024
Q3
2024
Sep 30, 2023
$1.67M
Nov 13, 2024
Q2
2024
Jun 30, 2023
$1.99M
Aug 14, 2024
Q1
2024
Mar 31, 2023
$2.52M
May 15, 2024
Q3
2022
Sep 30, 2022
$5.19M
Nov 15, 2022
Q2
2023
Jun 30, 2022
$4.19M
Aug 14, 2023
Q1
2023
Mar 31, 2022
$2.47M
May 15, 2023
Q3
2022
Sep 30, 2021
$2.15M
Nov 15, 2022
Q1
2021
Jun 30, 2021
$2.46M
Aug 16, 2021
Q2
2022
Jun 30, 2021
$2.46M
Aug 12, 2022
Q1
2022
Mar 31, 2021
$4.08M
May 16, 2022
Q3
2021
Sep 30, 2020
$3.46M
Nov 15, 2021
Q1
2021
Jun 30, 2020
$1.37M
Aug 16, 2021
Q1
2021
Mar 31, 2020
$1.79M
May 14, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($922.7K)
Nov 13, 2025
Q2
2025
Jun 30, 2025
$5.43M
Aug 14, 2025
Q1
2025
Mar 31, 2025
($2.26M)
May 15, 2025
Q3
2025
Sep 30, 2024
($2.22M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($662.0K)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($2.16M)
May 15, 2025
Q3
2024
Sep 30, 2023
($4.55M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($2.55M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($1.39M)
May 15, 2024
Q3
2023
Sep 30, 2022
($13.83M)
Nov 15, 2023
Q2
2023
Jun 30, 2022
($1.81M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($174.2K)
May 15, 2023
Q3
2022
Sep 30, 2021
($1.70M)
Nov 15, 2022
Q1
2021
Jun 30, 2021
($2.11M)
Aug 16, 2021
Q2
2022
Jun 30, 2021
($2.11M)
Aug 12, 2022
Q1
2022
Mar 31, 2021
$3.01M
May 16, 2022
Q3
2021
Sep 30, 2020
($3.30M)
Nov 15, 2021
Q1
2021
Jun 30, 2020
($5.76M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($6.08M)
May 14, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($990.7K)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($1.80M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($1.46M)
May 15, 2025
Q3
2025
Sep 30, 2024
($1.20M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($1.35M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($1.50M)
May 15, 2025
Q3
2024
Sep 30, 2023
($4.81M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($2.46M)
Aug 14, 2024
Q1
2024
Mar 31, 2023
($1.31M)
May 15, 2024
Q3
2023
Sep 30, 2022
($13.67M)
Nov 15, 2023
Q2
2023
Jun 30, 2022
($1.66M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($481.2K)
May 15, 2023
Q3
2022
Sep 30, 2021
($3.60M)
Nov 15, 2022
Q2
2022
Jun 30, 2021
($4.28M)
Aug 12, 2022
Q1
2021
Jun 30, 2021
($4.28M)
Aug 16, 2021
Q1
2022
Mar 31, 2021
($2.20M)
May 16, 2022
Q3
2021
Sep 30, 2020
($2.34M)
Nov 15, 2021
Q1
2021
Jun 30, 2020
($5.02M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($5.61M)
May 14, 2021